AI analytics predict COVID-19 patients’ daily trajectory in UK intensive care
Researchers used AI to identify which daily changing clinical parameters best predict intervention responses in critically ill COVID-19 patients.
Mental Health Awareness Week 10-16 May
Imperial is hosting various virtual activities for staff and students to help support our community
Key enzyme TPL-2 helps immune cells kill disease-causing bacteria
A new study sheds light on how the body’s response to bacterial infection is controlled in a key type of immune cell – the macrophage.
Novel Gold-coated SERS Filters for Diagnosis of Urinary Tract Infections
A Hamlyn-led project proposed novel gold-coated filters for diagnosis of urinary tract infections using surface enhanced Raman spectroscopy (SERS).
New study reveals weak spots in chemotherapy-resistant cancer cells
Molecular ‘weak spots' in cancer cells recovering from chemotherapy could provide the basis for better treatments, according to new research
€2.5m ERC Advanced grant to make AI more accessible for health and law
The European Research Council has awarded an Imperial College London researcher €2.5m to make AI more easily available in the areas of health and law.
New study to explore how well COVID-19 vaccines protect dialysis patients
A new study will assess how well COVID-19 vaccines work in people who attend hospital for their dialysis treatment (haemodialysis).
UK must invest to keep up with RNA vaccine revolution – Robin Shattock
Professor Robin Shattock says the UK needs to invest more in RNA vaccine technology to better prepare us for future pandemics.
UK Budget 2021: Imperial experts respond
Academics and researchers from across Imperial College London have provided analysis of the 2021 Spring budget.
Imperial researchers develop roadside barrier design to mitigate air pollution
Imperial researchers have designed a unique curved barrier which can protect people from the damaging effects of air pollution.
2
